Clinical Trial Update: Evaluation of Intravenous Dalbavancin for Peritonitis

View source ↗

Summary

The clinical trial evaluating intravenous dalbavancin for peritonitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Peritonitis
• Peritonitis

Drugs mentioned

• Dalbavancin (dalbavancin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Peritonitis, Peritonitis Bacterial | Status: TERMINATED